[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335773-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335773-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","impact-of-oncologic-diseases-on-outcome-in-patients-with-severe-isolated-tricuspid-regurgitation","Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitation","","Severe tricuspid regurgitation (TR) is linked to high morbidity and mortality, yet isolated TR lacks clear treatment options beyond interventional repair or replacement. When cancer survivorship or active oncologic therapy coexists with isolated severe TR, referral and intervention may be unnecessarily delayed, potentially worsening prognosis. An observational cohort from the Medical University of Vienna assessed cancer incidence, cancer subtype, and organ involvement among severe isolated TR patients with preserved left ventricular function, and evaluated long-term mortality differences across cancer status.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/impact-of-oncologic-diseases-on-outcome-in-patients-with-severe-isolated-tricuspid-regurgitation/335773/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/impact-of-oncologic-diseases-on-outcome-in-patients-with-severe-isolated-tricuspid-regurgitation/335773.png","ImageObject",300,407,{"name":42,"@type":43},"Valentina","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How was isolated severe tricuspid regurgitation defined in this study?","Question",{"text":63,"@type":64},"Isolated severe TR was defined as severe tricuspid regurgitation without overt heart disease, excluding significant left heart valve disease and other valvular lesions, with normal left ventricular function.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What patient groups were compared regarding cancer status?",{"text":68,"@type":64},"Patients with severe TR were classified into those with active cancer and those with a history of cancer at the time of TR diagnosis, and outcomes were compared with patients without cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"Which cancer characteristics were associated with the highest mortality?",{"text":72,"@type":64},"The highest mortality was observed among patients with lung cancer, active cancer, and multi-organ cancer.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335773,1790717495,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},13056703020460,"https://ap-avatar.wpscdn.com/avatar/be000253dac470eee5d?_k=1778207105932848923","DOI: 10. 1111/eci.14367  \nORIGINAL ARTICLE  \nImpact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitation  \nVarius Dannenberg1  | Flora Zschocke1 | Kseniya Halavina1 |  \nKatharina Mascherbauer1 | Gregor Heitzinger1 | Matthias Koschutnik1 |  \nCarolina Donà1 | Christian Nitsche1 | Andreas A. Kammerlander1 | Georg Spinka1 | Max-Paul Winter1  | Philipp E. Bartko1 | Christian Hengstenberg1 |  \nJutta Bergler-Klein1 | Georg Goliasch1 | Matthias Schneider-Reigbert2  \n1Department of Internal Medicine  \nII, Division of Cardiology, Medical University of Vienna, Vienna, Austria 2Department of Internal Medicine and Cardiology, Campus Virchow Klinikum, Charité—Universitätsmedizin Berlin, Berlin, Germany  \nCorrespondence  \nJutta Bergler-Klein, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18-20, A- 1090 Vienna, Austria.  \nEmail: jutta.bergler-klein@ [meduniwien.ac.at](meduniwien.ac.at)  \nAbstract  \nBackground: Severe tricuspid regurgitation (TR) is associated with high morbidity and mortality. Isolated TR, defined as TR without overt heart disease, is typical and offers limited cardiac treatment options other than interventional repair or replacement. Survival history of cancer or active cancer treatment may lead to an unnecessary delay of TR treatment.  \nMethods: We included all patients diagnosed with severe TR at the Medical University of Vienna between 2003 and 2016 who had normal left ventricular function and no other valvular lesions. Outcome analysis was performed on cancer type, status and the number of organs affected by cancer.  \nResults: A total of 973 patients were included. 182 (19%) patients had cancer, 52 were active and 130 had a history of cancer at the time of TR diagnosis. Oncologic patients were divided into subgroups of gastrointestinal, skin, glands, gynaecological, breast, urogenital, lung and other cancers. Ten-year mortality of patients with cancer was higher than those without cancer (p \u003C0.001). Multivariate analysis adjusting for age did not reveal significantly higher mortality in patients with a history of cancer compared to patients without cancer (p = 0.59) . Patients with lung, active, or multi-organ cancer showed the highest mortality.  \nConclusions: Mortality in patients with severe isolated TR is high and increased by active or multi-organ cancer but not by a history of cancer. These patients should be discussed in interdisciplinary cardio-oncology teams to avoid delaying life-saving treatment ofTR and cancer.  \nKEYWORDS  \nheart failure, oncologic diseases, right ventricle, tricuspid regurgitation  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2024 The Author(s). European Journal of Clinical Investigation published by John Wiley & Sons Ltd on behalf of Stichting European Society for Clinical Investigation Journal Foundation.  \nEur J Clin Invest. 2025;55:e14367 .  \n[https://doi.org/10.1111/eci.14367](https://doi.org/10.1111/eci.14367)  \n[wileyonlinelibrary.com/journal/eci](wileyonlinelibrary.com/journal/eci)  \n1 of 11  \n1 | INTRODUCTION  \nTricuspid regurgitation (TR) is a common condition in the general population. Approximately two percent of the total population and four percent of people ≥75years are affected by at least moderate TR.1 The overall outcome of TR is poor and worsens even further with increasing severity.2,3 This also applies to severe isolated TR, defined as TR without overt cardiac disease.4,5 TR is generally associated with right ventricular failure, which is of increasing interest in cardio-oncology due to therapeutic agents such as anthracyclines or trastuzumab known to cause reversible or irreversible right ventricular (RV) damage.6–8 Consequently, RV failure may worsen oncologic patients' prognosis.9 TR in oncolo","cbCailUiZz4CBFXH","https://ap.wps.com/l/cbCailUiZz4CBFXH","pdf",966859,11,"English","# Introduction\n## Study rationale and background\n## Study aims\n# Methods\n## Study design and population\n## Endpoints and follow-up\n# Results\n## Cancer incidence and cancer subgroups\n## Mortality comparisons and multivariate findings\n# Conclusions","[{\"question\":\"How was isolated severe tricuspid regurgitation defined in this study?\",\"answer\":\"Isolated severe TR was defined as severe tricuspid regurgitation without overt heart disease, excluding significant left heart valve disease and other valvular lesions, with normal left ventricular function.\"},{\"question\":\"What patient groups were compared regarding cancer status?\",\"answer\":\"Patients with severe TR were classified into those with active cancer and those with a history of cancer at the time of TR diagnosis, and outcomes were compared with patients without cancer.\"},{\"question\":\"Which cancer characteristics were associated with the highest mortality?\",\"answer\":\"The highest mortality was observed among patients with lung cancer, active cancer, and multi-organ cancer.\"}]","Impact of oncologic diseases on outcome in patients with severe isolated tricuspid regurgitation | PDF",1790012280,28]